Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	L-lactate dehydrogenase activity	LDHAL6A LDHAL6B LDHA LDHB	5.56e-08	5	207	4	GO:0004459
GeneOntologyMolecularFunction	lactate dehydrogenase activity	LDHAL6A LDHAL6B LDHA LDHB	1.66e-07	6	207	4	GO:0004457
GeneOntologyMolecularFunction	sulfonylurea receptor activity	ABCC8 ABCC9	1.07e-04	2	207	2	GO:0008281
GeneOntologyMolecularFunction	glycerol kinase activity	GK GK2	3.19e-04	3	207	2	GO:0004370
GeneOntologyMolecularFunction	threonine-tRNA ligase activity	TARS1 TARS3	3.19e-04	3	207	2	GO:0004829
GeneOntologyMolecularFunction	NACHT domain binding	TRIM16L CARD8	3.19e-04	3	207	2	GO:0032089
GeneOntologyMolecularFunction	immunoglobulin receptor activity	PIGR FCGR3B CD200R1	3.67e-04	14	207	3	GO:0019763
GeneOntologyMolecularFunction	channel regulator activity	PRSS8 ITPR1 KCNMB1 GNB2 FLNA ABCC9 SLC15A1 PRKACA	4.75e-04	174	207	8	GO:0016247
GeneOntologyMolecularFunction	transporter regulator activity	PRSS8 ITPR1 KCNMB1 GNB2 FLNA ABCC9 SLC15A1 PRKACA	5.32e-04	177	207	8	GO:0141108
GeneOntologyMolecularFunction	oxidoreductase activity, acting on CH-OH group of donors	LDHAL6A HAO1 MDH1B LDHAL6B LDHA LDHB UEVLD	5.99e-04	138	207	7	GO:0016614
GeneOntologyMolecularFunction	peptide:proton symporter activity	SLC15A3 SLC15A1	6.33e-04	4	207	2	GO:0015333
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRF PTPRH PTPRT	6.71e-04	17	207	3	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRF PTPRH PTPRT	6.71e-04	17	207	3	GO:0019198
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor	HAO1 AOX1	1.05e-03	5	207	2	GO:0016623
GeneOntologyMolecularFunction	cysteine-type endopeptidase activator activity	NLRP1 CARD8	1.05e-03	5	207	2	GO:0140608
GeneOntologyMolecularFunction	dipeptide transmembrane transporter activity	SLC15A3 SLC15A1	1.05e-03	5	207	2	GO:0071916
GeneOntologyCellularComponent	presynapse	PFN1 DYSF CNTN6 ITPR1 ADRA2C AP1B1 OTOF ABCC8 GRIN3A FER1L5 USH2A SEMA7A WDR7 DBNL PPFIA3 SLC6A1 EFNB2 TNN PRKACA CD47 CACNA2D3	1.76e-04	886	205	21	GO:0098793
GeneOntologyCellularComponent	potassium ion-transporting ATPase complex	ABCC8 ABCC9	2.85e-04	3	205	2	GO:0031004
GeneOntologyCellularComponent	cell body	CCT3 PDE10A ITPR1 ADRA2C HMCN2 PTPRF WASHC5 C4A C4B GRIN3A GNB1 GNB2 GNB3 USH2A ALK FLNA DBNL SLC6A1 TNN LRP1 CX3CR1	3.32e-04	929	205	21	GO:0044297
GeneOntologyCellularComponent	tenascin complex	TNC TNN	5.67e-04	4	205	2	GO:0090733
GeneOntologyCellularComponent	Myb complex	FLNA MYBL2	5.67e-04	4	205	2	GO:0031523
GeneOntologyCellularComponent	inward rectifying potassium channel	ABCC8 ABCC9	5.67e-04	4	205	2	GO:0008282
Domain	-	LDHAL6A MDH1B LDHAL6B LDHA LDHB UEVLD	1.25e-10	9	203	6	3.90.110.10
Domain	Lactate/malate_DH_C	LDHAL6A MDH1B LDHAL6B LDHA LDHB UEVLD	1.25e-10	9	203	6	IPR022383
Domain	Ldh_1_C	LDHAL6A MDH1B LDHAL6B LDHA LDHB UEVLD	1.25e-10	9	203	6	PF02866
Domain	Lactate_DH/Glyco_Ohase_4_C	LDHAL6A MDH1B LDHAL6B LDHA LDHB UEVLD	1.25e-10	9	203	6	IPR015955
Domain	Lactate/malate_DH_N	LDHAL6A LDHAL6B LDHA LDHB UEVLD	7.87e-09	8	203	5	IPR001236
Domain	L-lactate/malate_DH	LDHAL6A LDHAL6B LDHA LDHB UEVLD	7.87e-09	8	203	5	IPR001557
Domain	Ldh_1_N	LDHAL6A LDHAL6B LDHA LDHB UEVLD	7.87e-09	8	203	5	PF00056
Domain	L_LDH	LDHAL6A LDHAL6B LDHA LDHB	6.72e-08	5	203	4	PS00064
Domain	L-lactate_DH	LDHAL6A LDHAL6B LDHA LDHB	6.72e-08	5	203	4	IPR011304
Domain	L-lactate_DH_AS	LDHAL6A LDHAL6B LDHA LDHB	6.72e-08	5	203	4	IPR018177
Domain	Ig-like_fold	INSRR NCR3LG1 CNTN6 IGSF10 HMCN2 PTPRF PTPRH PIGR FCGR3B CD101 PKHD1 USH2A SDK1 IL23R FLNA SEMA7A TNC TRIM71 PTPRT CD200R1 HMCN1 IGFBP7 TNN CD47 GPA33	2.12e-07	706	203	25	IPR013783
Domain	-	INSRR NCR3LG1 CNTN6 IGSF10 PTPRF PIGR FCGR3B CD101 PKHD1 USH2A SDK1 IL23R FLNA SEMA7A TNC TRIM71 PTPRT CD200R1 HMCN1 IGFBP7 TNN CD47 GPA33	9.58e-07	663	203	23	2.60.40.10
Domain	fn3	INSRR CNTN6 PTPRF PTPRH USH2A SDK1 IL23R TNC PTPRT TNN	1.14e-05	162	203	10	PF00041
Domain	FerI	DYSF OTOF FER1L5	1.25e-05	5	203	3	SM01202
Domain	FerB	DYSF OTOF FER1L5	1.25e-05	5	203	3	SM01201
Domain	Ferlin_B-domain	DYSF OTOF FER1L5	1.25e-05	5	203	3	IPR012561
Domain	Anaphylatoxin_comp_syst	C4A C4B C5	1.25e-05	5	203	3	IPR018081
Domain	Ferlin_C	DYSF OTOF FER1L5	1.25e-05	5	203	3	PF16165
Domain	Ferlin_C	DYSF OTOF FER1L5	1.25e-05	5	203	3	IPR032362
Domain	FerIin_dom	DYSF OTOF FER1L5	1.25e-05	5	203	3	IPR012968
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B C5	1.25e-05	5	203	3	IPR001840
Domain	FerI	DYSF OTOF FER1L5	1.25e-05	5	203	3	PF08151
Domain	FerB	DYSF OTOF FER1L5	1.25e-05	5	203	3	PF08150
Domain	Guanine_nucleotide-bd_bsu	GNB1 GNB2 GNB3	1.25e-05	5	203	3	IPR016346
Domain	FN3	INSRR CNTN6 PTPRF PTPRH USH2A SDK1 IL23R TNC PTPRT TNN	3.58e-05	185	203	10	SM00060
Domain	ANATO	C4A C4B C5	4.29e-05	7	203	3	SM00104
Domain	ANAPHYLATOXIN_2	C4A C4B C5	4.29e-05	7	203	3	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B C5	4.29e-05	7	203	3	PS01177
Domain	ANATO	C4A C4B C5	4.29e-05	7	203	3	PF01821
Domain	Anaphylatoxin/fibulin	C4A C4B C5	4.29e-05	7	203	3	IPR000020
Domain	IG	NCR3LG1 CNTN6 IGSF10 HMCN2 PTPRF PIGR FCGR3B CD101 SDK1 SEMA7A PTPRT CD200R1 HMCN1 IGFBP7 GPA33	6.00e-05	421	203	15	SM00409
Domain	Ig_sub	NCR3LG1 CNTN6 IGSF10 HMCN2 PTPRF PIGR FCGR3B CD101 SDK1 SEMA7A PTPRT CD200R1 HMCN1 IGFBP7 GPA33	6.00e-05	421	203	15	IPR003599
Domain	FN3	INSRR CNTN6 PTPRF PTPRH USH2A SDK1 IL23R TNC PTPRT TNN	6.63e-05	199	203	10	PS50853
Domain	IG_LIKE	NCR3LG1 CNTN6 IGSF10 HMCN2 PTPRF PIGR FCGR3B CD101 SDK1 SEMA7A PTPRT CD200R1 HMCN1 IGFBP7 CD47 GPA33	9.73e-05	491	203	16	PS50835
Domain	FN3_dom	INSRR CNTN6 PTPRF PTPRH USH2A SDK1 IL23R TNC PTPRT TNN	9.97e-05	209	203	10	IPR003961
Domain	FIIND	NLRP1 CARD8	1.18e-04	2	203	2	PF13553
Domain	MAP3K12_MAP3K13	MAP3K12 MAP3K13	1.18e-04	2	203	2	IPR017419
Domain	Sulphorea_rcpt	ABCC8 ABCC9	1.18e-04	2	203	2	IPR000388
Domain	FIIND_dom	NLRP1 CARD8	1.18e-04	2	203	2	IPR025307
Domain	Ig-like_dom	NCR3LG1 CNTN6 IGSF10 HMCN2 PTPRF PIGR FCGR3B CD101 SDK1 SEMA7A PTPRT CD200R1 HMCN1 IGFBP7 CD47 GPA33	1.28e-04	503	203	16	IPR007110
Domain	Gprotein_B	GNB1 GNB2 GNB3	1.44e-04	10	203	3	IPR001632
Domain	A2M	C4A C4B C5	1.44e-04	10	203	3	PF00207
Domain	A2M_N_2	C4A C4B C5	1.44e-04	10	203	3	IPR011625
Domain	A2M_comp	C4A C4B C5	1.44e-04	10	203	3	IPR011626
Domain	A2M_recep	C4A C4B C5	1.44e-04	10	203	3	PF07677
Domain	A2M_comp	C4A C4B C5	1.44e-04	10	203	3	PF07678
Domain	A2M_N	C4A C4B C5	1.44e-04	10	203	3	PF01835
Domain	A2M_N	C4A C4B C5	1.44e-04	10	203	3	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B C5	1.44e-04	10	203	3	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B C5	1.44e-04	10	203	3	PS00477
Domain	A2M_N_2	C4A C4B C5	1.44e-04	10	203	3	PF07703
Domain	Macroglobln_a2	C4A C4B C5	1.44e-04	10	203	3	IPR001599
Domain	Growth_fac_rcpt_	INSRR FAT1 HMCN2 TNC HMCN1 IGFBP7 TNN LRP1	3.12e-04	156	203	8	IPR009030
Domain	Sox_N	SOX9 SOX8	3.50e-04	3	203	2	IPR022151
Domain	FerA	DYSF FER1L5	3.50e-04	3	203	2	SM01200
Domain	Ferlin_A-domain	DYSF FER1L5	3.50e-04	3	203	2	IPR012560
Domain	Sox_N	SOX9 SOX8	3.50e-04	3	203	2	PF12444
Domain	Carb_kinase_FGGY_CS	GK GK2	3.50e-04	3	203	2	IPR018483
Domain	FerA	DYSF FER1L5	3.50e-04	3	203	2	PF08165
Domain	ThrRS_core	TARS1 TARS3	3.50e-04	3	203	2	IPR033728
Domain	Thr-tRNA-ligase_IIa	TARS1 TARS3	3.50e-04	3	203	2	IPR002320
Domain	PTR2_1	SLC15A3 SLC15A1	3.50e-04	3	203	2	PS01022
Domain	-	TARS1 AOX1 TARS3	4.22e-04	14	203	3	3.10.20.30
Domain	Beta-grasp_dom	TARS1 AOX1 TARS3	4.22e-04	14	203	3	IPR012675
Domain	-	LDHAL6A MDH1B LDHAL6B RTN4IP1 LDHA LDHB TGDS UEVLD	5.32e-04	169	203	8	3.40.50.720
Domain	NAD(P)-bd_dom	LDHAL6A MDH1B LDHAL6B RTN4IP1 LDHA LDHB TGDS UEVLD	6.21e-04	173	203	8	IPR016040
Domain	MAM_1	MEP1B ALK PTPRT	6.38e-04	16	203	3	PS00740
Domain	VDCC_a2/dsu	CACNA2D4 CACNA2D3	6.95e-04	4	203	2	IPR013680
Domain	G2F	HMCN2 HMCN1	6.95e-04	4	203	2	PF07474
Domain	NIDOGEN_G2	HMCN2 HMCN1	6.95e-04	4	203	2	PS50993
Domain	VGCC_alpha2	CACNA2D4 CACNA2D3	6.95e-04	4	203	2	PF08473
Domain	DysFC	DYSF FER1L5	6.95e-04	4	203	2	SM00694
Domain	DysFN	DYSF FER1L5	6.95e-04	4	203	2	SM00693
Domain	GFP	HMCN2 HMCN1	6.95e-04	4	203	2	IPR009017
Domain	-	C4A C5	6.95e-04	4	203	2	1.20.91.20
Domain	Glycerol_kin	GK GK2	6.95e-04	4	203	2	IPR005999
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	6.95e-04	4	203	2	IPR006605
Domain	Peroxin/Ferlin	DYSF FER1L5	6.95e-04	4	203	2	IPR006614
Domain	PTR2_2	SLC15A3 SLC15A1	6.95e-04	4	203	2	PS01023
Domain	C345C	C4A C4B C5	7.69e-04	17	203	3	SM00643
Domain	MAM	MEP1B ALK PTPRT	9.15e-04	18	203	3	PF00629
Domain	MAM_dom	MEP1B ALK PTPRT	9.15e-04	18	203	3	IPR000998
Domain	Terpenoid_cyclase/PrenylTrfase	C4A C4B C5	9.15e-04	18	203	3	IPR008930
Domain	MAM_2	MEP1B ALK PTPRT	9.15e-04	18	203	3	PS50060
Domain	NTR	C4A C4B C5	1.08e-03	19	203	3	PF01759
Domain	Netrin_module_non-TIMP	C4A C4B C5	1.08e-03	19	203	3	IPR018933
Domain	Ig_I-set	CNTN6 IGSF10 HMCN2 PTPRF CD101 SDK1 HMCN1 IGFBP7	1.14e-03	190	203	8	IPR013098
Domain	I-set	CNTN6 IGSF10 HMCN2 PTPRF CD101 SDK1 HMCN1 IGFBP7	1.14e-03	190	203	8	PF07679
Domain	POT_fam	SLC15A3 SLC15A1	1.15e-03	5	203	2	IPR000109
Domain	PTR2	SLC15A3 SLC15A1	1.15e-03	5	203	2	PF00854
Domain	VWA_N	CACNA2D4 CACNA2D3	1.15e-03	5	203	2	IPR013608
Domain	FGGY_KINASES_1	GK GK2	1.15e-03	5	203	2	PS00933
Domain	VWA_N	CACNA2D4 CACNA2D3	1.15e-03	5	203	2	PF08399
Domain	Carb_kinase_FGGY_C	GK GK2	1.15e-03	5	203	2	IPR018485
Domain	FGGY_KINASES_2	GK GK2	1.15e-03	5	203	2	PS00445
Domain	IGv	IGSF10 PIGR CD101 HMCN1 GPA33	1.35e-03	75	203	5	SM00406
Domain	Carb_kinase_FGGY_N	GK GK2	1.71e-03	6	203	2	IPR018484
Domain	TGS	TARS1 TARS3	1.71e-03	6	203	2	IPR004095
Domain	TGS	TARS1 TARS3	1.71e-03	6	203	2	PF02824
Domain	FGGY_C	GK GK2	1.71e-03	6	203	2	PF02782
Pathway	REACTOME_REGULATION_OF_INSULIN_SECRETION	ITPR1 ADRA2C ABCC8 GNB1 GNB2 GNB3 PRKACA PRKACB	2.90e-07	61	153	8	MM15071
Pathway	REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	ITPR1 GNB1 GNB2 GNB3 PRKACA PRKACB	1.06e-06	32	153	6	MM14983
Pathway	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	ITPR1 ADRA2C ABCC8 GNB1 GNB2 GNB3 PRKACA PRKACB	1.07e-06	72	153	8	MM14631
Pathway	REACTOME_REGULATION_OF_INSULIN_SECRETION	ITPR1 ADRA2C ABCC8 GNB1 GNB2 GNB3 PRKACA PRKACB	1.98e-06	78	153	8	M1921
Pathway	REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	ITPR1 GNB1 GNB2 GNB3 PRKACA PRKACB	5.63e-06	42	153	6	M791
Pathway	REACTOME_GPER1_SIGNALING	GNB1 GNB2 GNB3 PRKACA PRKACB	9.39e-06	27	153	5	MM15664
Pathway	REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS	GNB1 GNB2 GNB3 PRKACA PRKACB	1.91e-05	31	153	5	MM15094
Pathway	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	ITPR1 ADRA2C ABCC8 GNB1 GNB2 GNB3 PRKACA PRKACB	2.26e-05	108	153	8	M17034
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	GNB1 GNB2 GNB3 PRKACA PRKACB	2.62e-05	33	153	5	M11575
Pathway	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	ABCC8 GNB1 GNB2 GNB3 ABCC9	3.52e-05	35	153	5	M1075
Pathway	REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	ABCC8 GNB1 GNB2 GNB3 ABCC9	4.05e-05	36	153	5	MM14544
Pathway	REACTOME_ACTIVATION_OF_C3_AND_C5	C4A C4B C5	4.25e-05	7	153	3	MM14685
Pathway	REACTOME_ACTIVATION_OF_C3_AND_C5	C4A C4B C5	6.75e-05	8	153	3	M27031
Pathway	KEGG_PYRUVATE_METABOLISM	LDHAL6A DLD LDHAL6B LDHA LDHB	6.83e-05	40	153	5	M7934
Pathway	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	GNB1 GNB2 GNB3 PRKACA PRKACB	6.83e-05	40	153	5	MM15115
Pathway	REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS	GNB1 GNB2 GNB3 PRKACA PRKACB	9.74e-05	43	153	5	M933
Pathway	REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION	GNB1 GNB2 GNB3 PRKACA PRKACB	9.74e-05	43	153	5	M29837
Pathway	REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION	ADRA2C GNB1 GNB2 GNB3	1.01e-04	23	153	4	MM15033
Pathway	REACTOME_GPER1_SIGNALING	GNB1 GNB2 GNB3 PRKACA PRKACB	1.21e-04	45	153	5	M45008
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOLYSIS	LDHAL6A LDHAL6B LDHA LDHB	1.41e-04	25	153	4	M47623
Pathway	REACTOME_NEURONAL_SYSTEM	PTPRF ABCC8 KCNMB1 GRIN3A GNB1 GNB2 GNB3 DBNL ABCC9 PPFIA3 SLC6A1 PRKACA PRKACB CACNA2D3	1.55e-04	411	153	14	M735
Pathway	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	RGS22 MCHR2 HCAR1 ITPR1 ADRA2C C5 GNB1 GNB2 GNB3 PRKACA PRKACB CX3CR1	1.62e-04	314	153	12	M600
Pathway	REACTOME_PYRUVATE_METABOLISM	LDHAL6A DLD LDHAL6B LDHA LDHB	1.83e-04	49	153	5	M17157
Pathway	BIOCARTA_LECTIN_PATHWAY	C4A C4B C5	1.94e-04	11	153	3	MM1430
Pathway	REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION	ADRA2C GNB1 GNB2 GNB3	2.23e-04	28	153	4	M10679
Pathway	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	GNB1 GNB2 GNB3 PRKACA PRKACB	2.43e-04	52	153	5	M920
Pathway	BIOCARTA_CLASSIC_PATHWAY	C4A C4B C5	2.57e-04	12	153	3	MM1368
Pathway	REACTOME_NEURONAL_SYSTEM	PTPRF ABCC8 GRIN3A GNB1 GNB2 GNB3 ABCC9 PPFIA3 SLC6A1 PRKACA PRKACB CACNA2D3	2.94e-04	335	153	12	MM14503
Pathway	BIOCARTA_LECTIN_PATHWAY	C4A C4B C5	3.31e-04	13	153	3	M4732
Pathway	REACTOME_PLATELET_HOMEOSTASIS	PDE10A ITPR1 KCNMB1 GNB1 GNB2 GNB3	3.41e-04	86	153	6	M916
Pathway	KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY	GNB1 GNB2 GNB3 LPAR6	3.79e-04	32	153	4	M47962
Pathway	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	ADRA2C GNB1 GNB2 GNB3	4.27e-04	33	153	4	MM15058
Pathway	KEGG_PROPANOATE_METABOLISM	LDHAL6A LDHAL6B LDHA LDHB	4.27e-04	33	153	4	M4086
Pathway	REACTOME_OPIOID_SIGNALLING	ITPR1 GNB1 GNB2 GNB3 PRKACA PRKACB	4.36e-04	90	153	6	M6467
Pathway	WP_G_PROTEIN_SIGNALING	ITPR1 GNB1 GNB2 GNB3 PRKACA PRKACB	4.62e-04	91	153	6	M39426
Pathway	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	LDHAL6A LDHAL6B LDHA LDHB	4.80e-04	34	153	4	M10911
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	GRIN3A GNB1 GNB2 GNB3 PPFIA3 SLC6A1 PRKACA PRKACB CACNA2D3	4.93e-04	211	153	9	MM14502
Pathway	BIOCARTA_CLASSIC_PATHWAY	C4A C4B C5	5.18e-04	15	153	3	M7146
Pathway	KEGG_GLYCOLYSIS_GLUCONEOGENESIS	LDHAL6A DLD LDHAL6B LDHA LDHB	5.55e-04	62	153	5	M11521
Pathway	REACTOME_CA2_PATHWAY	ITPR1 FZD4 GNB1 GNB2 GNB3	5.55e-04	62	153	5	M27321
Pathway	REACTOME_CGMP_EFFECTS	PDE10A ITPR1 KCNMB1	6.33e-04	16	153	3	M902
Pathway	REACTOME_TRIGLYCERIDE_METABOLISM	GK GK2 PRKACA PRKACB	7.39e-04	38	153	4	M27856
Pathway	REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING	CCT3 GNB1 GNB2 GNB3	7.39e-04	38	153	4	M27656
Pathway	WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY	C4A C4B C5	7.62e-04	17	153	3	MM15944
Pathway	BIOCARTA_COMP_PATHWAY	C4A C4B C5	7.62e-04	17	153	3	MM1369
Pathway	KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACB CX3CR1	7.62e-04	17	153	3	M47544
Pathway	REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING	CCT3 GNB1 GNB2 GNB3	8.17e-04	39	153	4	MM15003
Pathway	REACTOME_POTASSIUM_CHANNELS	ABCC8 KCNMB1 GNB1 GNB2 GNB3 ABCC9	8.92e-04	103	153	6	M1073
Pathway	KEGG_CHEMOKINE_SIGNALING_PATHWAY	CCL18 GNB1 GNB2 GNB3 CSK PRKACA PRKACB CX3CR1	1.03e-03	188	153	8	M4844
Pathway	REACTOME_OPIOID_SIGNALLING	GNB1 GNB2 GNB3 PRKACA PRKACB	1.03e-03	71	153	5	MM14491
Pathway	REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	GNB1 GNB2 GNB3	1.07e-03	19	153	3	M926
Pathway	REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	GNB1 GNB2 GNB3	1.07e-03	19	153	3	MM15021
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	PRKACA PRKACB	1.15e-03	5	153	2	M26988
Pathway	REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION	NOP2 MYBL2	1.15e-03	5	153	2	M27770
Pathway	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42	GNB1 GNB2 GNB3	1.25e-03	20	153	3	M27853
Pathway	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42	GNB1 GNB2 GNB3	1.25e-03	20	153	3	MM15572
Pathway	BIOCARTA_COMP_PATHWAY	C4A C4B C5	1.25e-03	20	153	3	M917
Pathway	REACTOME_PYRUVATE_METABOLISM	DLD LDHAL6B LDHA LDHB	1.29e-03	44	153	4	MM15393
Pathway	REACTOME_PLATELET_HOMEOSTASIS	PDE10A ITPR1 GNB1 GNB2 GNB3	1.40e-03	76	153	5	MM15051
Pathway	REACTOME_CA2_PATHWAY	FZD4 GNB1 GNB2 GNB3	1.41e-03	45	153	4	MM15040
Pathway	WP_GLYCOLYSIS_AND_GLUCONEOGENESIS	DLD LDHAL6B LDHA LDHB	1.41e-03	45	153	4	M39474
Pathway	REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS	GNB1 GNB2 GNB3	1.44e-03	21	153	3	M27409
Pathway	REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS	GNB1 GNB2 GNB3	1.44e-03	21	153	3	MM15159
Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12	GNB1 GNB2 GNB3	1.66e-03	22	153	3	M841
Pathway	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	PDE10A ITPR1 KCNMB1	1.66e-03	22	153	3	M915
Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12	GNB1 GNB2 GNB3	1.66e-03	22	153	3	MM15016
Pathway	WP_COMPLEMENT_ACTIVATION	C4A C4B C5	1.66e-03	22	153	3	M39502
Pathway	WP_NICOTINE_METABOLISM_IN_LIVER_CELLS	AOX1 UGT1A4	1.71e-03	6	153	2	M39600
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	PRKACA PRKACB	1.71e-03	6	153	2	MM14628
Pathway	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	ADRA2C GNB1 GNB2 GNB3	1.79e-03	48	153	4	M10775
Pathway	KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY	GNB1 GNB2 GNB3	1.89e-03	23	153	3	M47549
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	BPNT1 SULT1C2 SULT2A1	1.89e-03	23	153	3	MM14597
Pathway	REACTOME_G_PROTEIN_ACTIVATION	GNB1 GNB2 GNB3	2.15e-03	24	153	3	MM14794
Pathway	REACTOME_G_PROTEIN_ACTIVATION	GNB1 GNB2 GNB3	2.15e-03	24	153	3	M13115
Pathway	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	GNB1 GNB2 GNB3	2.15e-03	24	153	3	MM15088
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	BPNT1 SULT1C2 SULT2A1	2.15e-03	24	153	3	M16289
Pathway	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	GNB1 GNB2 GNB3	2.15e-03	24	153	3	M18308
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY	GNB1 GNB2 GNB3	2.15e-03	24	153	3	M47460
Pathway	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	PFN1 ITPR1 ADRA2C GNB1 GNB2 GNB3 FLNA CSK CLEC3B	2.19e-03	261	153	9	M1077
Pathway	WP_GLYCOLYSIS_AND_GLUCONEOGENESIS	DLD LDHAL6B LDHA LDHB	2.24e-03	51	153	4	MM15928
Pathway	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	FZR1 ANAPC1 MOS PRKACA PRKACB	2.30e-03	85	153	5	M3578
Pathway	KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME	PRKACA PRKACB	2.37e-03	7	153	2	M47896
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACB	2.37e-03	7	153	2	MM15560
Pathway	KEGG_TASTE_TRANSDUCTION	GNB1 GNB3 PRKACA PRKACB	2.41e-03	52	153	4	M5785
Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1	GNB1 GNB2 GNB3	2.42e-03	25	153	3	M811
Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1	GNB1 GNB2 GNB3	2.42e-03	25	153	3	MM15056
Pathway	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	GNB1 GNB2 GNB3	2.42e-03	25	153	3	M14301
Pathway	REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	GNB1 GNB2 GNB3	2.71e-03	26	153	3	MM15017
Pathway	KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY	GNB1 GNB2 GNB3	2.71e-03	26	153	3	M47561
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY	GNB1 GNB2 GNB3	2.71e-03	26	153	3	M47562
Pathway	KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY	GNB1 GNB2 GNB3	2.71e-03	26	153	3	M47557
Pathway	KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY	GNB1 GNB2 GNB3	2.71e-03	26	153	3	M47456
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	GRIN3A GNB1 GNB2 GNB3 PPFIA3 SLC6A1 PRKACA PRKACB CACNA2D3	2.75e-03	270	153	9	M15514
Pathway	WP_G_PROTEIN_SIGNALING_PATHWAYS	ITPR1 GNB1 GNB3 PRKACA PRKACB	2.96e-03	90	153	5	MM15882
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	PRSS8 LDHAL6A CCT3 PFN1 DYSF PIGR FCGR3B SMPDL3A C4A C4B C5 GNB1 GNB2 GNB3 FLNA WWP2 LDHA LDHB NAMPT HMCN1 IGFBP7 RNPEP PRKACA PRKACB CNDP2 CLEC3B FUCA1 UEVLD	1.03e-10	1070	212	28	23533145
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	PRSS8 CCT3 ACTBL2 TM7SF3 PFN1 DYSF FAT1 GK GK2 PIGR PKHD1 C5 GNB1 ALK FLNA DYNC2H1 MINK1 VPS50 DBNL AOX1 LDHA LDHB RNPEP CSK CNDP2 FUCA1 UEVLD	1.64e-10	1016	212	27	19056867
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CCT3 MYO7A CYTH2 ACTBL2 PFN1 AP1B1 SACS WASHC5 MIOS DLD C4A C4B GNB1 GNB2 GNB3 TARS1 FLNA WDR7 TNC MINK1 DBNL PPFIA3 LDHA LDHB SLC6A1 TARS3 RNPEP PRKACA PLCH1 CACNA2D3	3.92e-09	1431	212	30	37142655
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	CDK12 ITPR1 DOCK5 SMYD4 RINT1 TMEM62 AP1B1 WASHC5 LPGAT1 C4A C4B CLEC16A ALG1 MOCOS MINK1 SMG8 NAMPT PLCH1	1.18e-07	650	212	18	38777146
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	INSRR GPR63 TLR7 PIGR ALK IL23R CD200R1 LRP1	2.08e-07	101	212	8	23382219
Pubmed	Genomic organization of the murine G protein beta subunit genes and related processed pseudogenes.	GNB1 GNB2 GNB3	2.23e-07	3	212	3	11913780
Pubmed	Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.	C4A C4B C5	2.23e-07	3	212	3	8649451
Pubmed	Impaired mast cell-dependent natural immunity in complement C3-deficient mice.	C4A C4B C5	8.89e-07	4	212	3	9367154
Pubmed	Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first.	C4A C4B C5	8.89e-07	4	212	3	8015436
Pubmed	Hemicentin-1 is an essential extracellular matrix component of the dermal-epidermal and myotendinous junctions.	HMCN2 TNC HMCN1	8.89e-07	4	212	3	34504132
Pubmed	Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism.	MYO7A PCDH15 USH2A	8.89e-07	4	212	3	18463160
Pubmed	Diversity among the beta subunits of heterotrimeric GTP-binding proteins: characterization of a novel beta-subunit cDNA.	GNB1 GNB2 GNB3	8.89e-07	4	212	3	1543505
Pubmed	The role of G protein beta subunits in the release of ATP from human erythrocytes.	GNB1 GNB2 GNB3	8.89e-07	4	212	3	12512701
Pubmed	Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.	IL23R FFAR2 CX3CR1	8.89e-07	4	212	3	33539767
Pubmed	The cationic region of Rhes mediates its interactions with specific Gbeta subunits.	GNB1 GNB2 GNB3	8.89e-07	4	212	3	19255495
Pubmed	Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.	C4A C4B C5	2.21e-06	5	212	3	15192652
Pubmed	Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.	C4A C4B C5	2.21e-06	5	212	3	17200182
Pubmed	Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency.	C4A C4B C5	2.21e-06	5	212	3	25039245
Pubmed	Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy.	C4A C4B CX3CR1	2.21e-06	5	212	3	29743491
Pubmed	Mitogen-activated protein kinase activation requires two signal inputs from the human anaphylatoxin C5a receptor.	C5 GNB1 GNB2	2.21e-06	5	212	3	7649993
Pubmed	Formation of high affinity C5 convertase of the classical pathway of complement.	C4A C4B C5	2.21e-06	5	212	3	12878586
Pubmed	Predominant role for C5b-9 in renal ischemia/reperfusion injury.	C4A C4B C5	2.21e-06	5	212	3	10811844
Pubmed	Identification of Gnr1p, a negative regulator of G alpha signalling in Schizosaccharomyces pombe, and its complementation by human G beta subunits.	GNB1 GNB2 GNB3	4.41e-06	6	212	3	16884933
Pubmed	Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H.	C4A C4B C5	4.41e-06	6	212	3	16849499
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CCT3 PFN1 DOCK5 FAT1 DHCR7 NOP2 CLEC16A SDK1 TARS1 TDRKH WDR7 MINK1 LDHA LDHB LIG1 EFNB2 ZBED6	6.48e-06	777	212	17	35844135
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	CCT3 ITPR1 AP1B1 DLD GNB1 GNB2 GNB3 MINK1 ABCC9 PPFIA3 LDHA LDHB SLC6A1 PRKACA PRKACB	7.23e-06	621	212	15	22794259
Pubmed	Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.	C4A C4B C5	7.68e-06	7	212	3	14660741
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CCT3 ACTBL2 PFN1 AP1B1 DHCR7 LPGAT1 DLD GNB2 TARS1 FLNA DYNC2H1 AP1M2 LDHA EPG5 NAMPT PRKACA CNDP2	1.06e-05	807	212	17	30575818
Pubmed	C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens.	C4A C4B C5	1.22e-05	8	212	3	24474777
Pubmed	Gβγ interacts with mTOR and promotes its activation.	GNB1 GNB2 GNB3	1.22e-05	8	212	3	24462769
Pubmed	The gene for the beta-subunit of retinal transducin (Gnb-1) maps to distal mouse chromosome 4, and related sequences map to mouse chromosomes 5 and 8.	GNB1 GNB2 GNB3	1.22e-05	8	212	3	2328987
Pubmed	Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.	C4A C4B C5	1.22e-05	8	212	3	28301559
Pubmed	Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping.	C4A C4B CX3CR1	1.22e-05	8	212	3	30173917
Pubmed	A G protein gamma subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gbeta5 subunits.	GNB1 GNB2 GNB3	1.22e-05	8	212	3	9789084
Pubmed	Microarray-based mutation analysis of 183 Spanish families with Usher syndrome.	MYO7A PCDH15 USH2A	1.22e-05	8	212	3	19683999
Pubmed	The role of complement in cryoglobulin-induced immune complex glomerulonephritis.	C4A C4B C5	1.22e-05	8	212	3	16272350
Pubmed	UMD-USHbases: a comprehensive set of databases to record and analyse pathogenic mutations and unclassified variants in seven Usher syndrome causing genes.	MYO7A PCDH15 USH2A	1.22e-05	8	212	3	18484607
Pubmed	Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.	MYO7A PCDH15 USH2A	1.22e-05	8	212	3	16545802
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	DIS3L CDK12 PFN1 FZR1 AP1B1 ANAPC1 USH2A NOP2 TARS1 FLNA DYNC2H1 LDHA LDHB FUCA1 EIF3I	1.76e-05	670	212	15	22990118
Pubmed	Fidelity of G protein beta-subunit association by the G protein gamma-subunit-like domains of RGS6, RGS7, and RGS11.	GNB1 GNB2 GNB3	1.83e-05	9	212	3	10339615
Pubmed	Ellis-van Creveld Syndrome	DYNC2H1 PRKACA PRKACB	1.83e-05	9	212	3	37903214
Pubmed	Hoxa5 Activity Across the Lateral Somitic Frontier Regulates Development of the Mouse Sternum.	SOX9 TNC TNN	1.83e-05	9	212	3	35557949
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CCT3 RGS22 PFN1 TTC3 ANAPC1 DHCR7 INTS11 GNL2 DLD GNB1 NOP2 TARS1 FLNA DYNC2H1 DBNL LDHA LDHB NAMPT RNPEP PRKACA CD47 EIF3I HDGF	2.24e-05	1425	212	23	30948266
Pubmed	Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.	MYO7A PCDH15 USH2A	2.60e-05	10	212	3	24618850
Pubmed	Expression of olfactory receptors, G-proteins and AxCAMs during the development and maturation of olfactory sensory neurons in the mouse.	GNB1 GNB2 GNB3	2.60e-05	10	212	3	9733924
Pubmed	Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.	C4A C4B C5	2.60e-05	10	212	3	30429287
Pubmed	Usher protein functions in hair cells and photoreceptors.	MYO7A PCDH15 USH2A	2.60e-05	10	212	3	24239741
Pubmed	Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex.	GNB1 GNB2 GNB3	2.60e-05	10	212	3	28334111
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TCAF1 CCT3 CYTH2 TTC3 TMEM132B AP1B1 ANAPC1 MIOS GNB1 GNB2 NOP2 TOP3B WDR7 MINK1 PPFIA3 PRKACA PRKACB LRP1	2.84e-05	963	212	18	28671696
Pubmed	Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.	CCT3 ACTBL2 PTPRF AP1B1 DHCR7 GNB1 GNB2 GNB3 AP1M2	3.02e-05	256	212	9	24189400
Pubmed	Huntingtin interacting proteins are genetic modifiers of neurodegeneration.	LDHAL6A ITPR1 DLD GNB1 GNB2 LDHA LDHB SLC6A1	3.04e-05	197	212	8	17500595
Pubmed	Neural crest-specific loss of Prkar1a causes perinatal lethality resulting from defects in intramembranous ossification.	SOX9 PRKACA PRKACB	3.55e-05	11	212	3	20534695
Pubmed	A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation.	GNB1 GNB2 GNB3	3.55e-05	11	212	3	25982117
Pubmed	The G protein subunit gene families.	GNB1 GNB2 GNB3	3.55e-05	11	212	3	10644457
Pubmed	Origin and possible roles of the Sox8 transcription factor gene during sexual development.	SOX9 SOX8	3.70e-05	2	212	2	14689607
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	3.70e-05	2	212	2	19062096
Pubmed	Association of an exonic LDHA polymorphism with altered respiratory response in probands at high risk for panic disorder.	LDHA LDHB	3.70e-05	2	212	2	12555229
Pubmed	Evidence of genetic heterogeneity in Alberta Hutterites with Usher syndrome type I.	MYO7A PCDH15	3.70e-05	2	212	2	22690115
Pubmed	Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression in human T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis.	CCL18 CX3CR1	3.70e-05	2	212	2	17900259
Pubmed	CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain.	NLRP1 CARD8	3.70e-05	2	212	2	22087307
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	3.70e-05	2	212	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	3.70e-05	2	212	2	12207352
Pubmed	Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB	3.70e-05	2	212	2	3023318
Pubmed	Mutations in myosin VIIA (MYO7A) and usherin (USH2A) in Spanish patients with Usher syndrome types I and II, respectively.	MYO7A USH2A	3.70e-05	2	212	2	12112664
Pubmed	M-LDH serves as a regulatory subunit of the cytosolic substrate-channelling complex in vivo.	LDHA LDHB	3.70e-05	2	212	2	17572440
Pubmed	p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.	CHEK1 CHEK2	3.70e-05	2	212	2	15601819
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	3.70e-05	2	212	2	27758680
Pubmed	Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: implication for receptor-mediated endocytosis.	PRKACA LRP1	3.70e-05	2	212	2	11158305
Pubmed	Molecular determinants of ATP-sensitive potassium channel MgATPase activity: diabetes risk variants and diazoxide sensitivity.	ABCC8 ABCC9	3.70e-05	2	212	2	26181369
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	3.70e-05	2	212	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	3.70e-05	2	212	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	3.70e-05	2	212	2	4216347
Pubmed	Checkpoint kinase 1 prevents cell cycle exit linked to terminal cell differentiation.	CHEK1 CHEK2	3.70e-05	2	212	2	21791608
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	3.70e-05	2	212	2	8428773
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	3.70e-05	2	212	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	3.70e-05	2	212	2	21345967
Pubmed	LDHA and LDHB are dispensable for aerobic glycolysis in neuroblastoma cells while promoting their aggressiveness.	LDHA LDHB	3.70e-05	2	212	2	30610122
Pubmed	Tripping the wire: sensing of viral protease activity by CARD8 and NLRP1 inflammasomes.	NLRP1 CARD8	3.70e-05	2	212	2	37311351
Pubmed	PKA mediates modality-specific modulation of the mechanically gated ion channel PIEZO2.	PIEZO2 PRKACA	3.70e-05	2	212	2	37146970
Pubmed	The complement component C4 of mammals.	C4A C4B	3.70e-05	2	212	2	2302180
Pubmed	Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif.	CHEK1 CHEK2	3.70e-05	2	212	2	17464182
Pubmed	Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy.	LDHA LDHB	3.70e-05	2	212	2	23266049
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	3.70e-05	2	212	2	22151770
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	3.70e-05	2	212	2	29080553
Pubmed	Multiple features contribute to efficient constitutive splicing of an unusually large exon.	PIGR TMEM121B	3.70e-05	2	212	2	11376148
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	3.70e-05	2	212	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	3.70e-05	2	212	2	17728371
Pubmed	Structure and organization of the C4 genes.	C4A C4B	3.70e-05	2	212	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	3.70e-05	2	212	2	6149581
Pubmed	Molecular cloning and functional expression of a cDNA encoding a new member of mixed lineage protein kinase from human brain.	MAP3K12 MAP3K13	3.70e-05	2	212	2	9353328
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	3.70e-05	2	212	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	3.70e-05	2	212	2	2387317
Pubmed	Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.	PRKACA PRKACB	3.70e-05	2	212	2	36152045
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	3.70e-05	2	212	2	7365238
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	3.70e-05	2	212	2	17971360
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	3.70e-05	2	212	2	17971229
Pubmed	Genome-wide identification of Sox8-, and Sox9-dependent genes during early post-natal testis development in the mouse.	SOX9 SOX8	3.70e-05	2	212	2	23315995
Pubmed	SOX9 keeps growth plates and articular cartilage healthy by inhibiting chondrocyte dedifferentiation/osteoblastic redifferentiation.	SOX9 SOX8	3.70e-05	2	212	2	33597301
Pubmed	Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.	C4A C4B	3.70e-05	2	212	2	35898513
Pubmed	Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.	C4A C4B	3.70e-05	2	212	2	28873507
GeneFamily	Fibronectin type III domain containing	INSRR CNTN6 PTPRF PTPRH USH2A SDK1 TNC PTPRT TNN	3.41e-06	160	136	9	555
GeneFamily	Ferlin family	DYSF OTOF FER1L5	8.19e-06	6	136	3	828
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CNTN6 IGSF10 HMCN2 PTPRF CD101 SDK1 HMCN1 IGFBP7	2.98e-05	161	136	8	593
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B C5	3.38e-05	9	136	3	1234
GeneFamily	Immunoglobulin like domain containing	HMCN2 FCGR3B CD101 SDK1 SEMA7A PTPRT CD47 GPA33	1.07e-04	193	136	8	594
GeneFamily	Glycosyltransferase family 6\|Blood group antigens	GCNT2 C4A C4B SEMA7A	1.67e-04	37	136	4	454
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRF PTPRH PTPRT	5.01e-04	21	136	3	813
GeneFamily	Glycerol kinases	GK GK2	8.26e-04	6	136	2	568
GeneFamily	NOP2/Sun RNA methyltransferase family	NOP2 NSUN7	1.15e-03	7	136	2	664
GeneFamily	Fibulins	HMCN2 HMCN1	1.53e-03	8	136	2	556
GeneFamily	Complement system\|Sushi domain containing	C4A C4B C5	2.48e-03	36	136	3	492
GeneFamily	ATP binding cassette subfamily C	ABCC8 ABCC9	4.15e-03	13	136	2	807
GeneFamily	Sulfotransferases, cytosolic	SULT1C2 SULT2A1	4.82e-03	14	136	2	762
GeneFamily	C-type lectin domain family	CLEC16A MRC1 CLEC3B	5.30e-03	47	136	3	494
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	SLC15A3 FZD4 IGSF10 FAT1 PTPRF C4A C4B ADAMTS2 TNC ABCC9 PIEZO2 HMCN1 IGFBP7 ATRNL1 LRP1 CLEC3B	1.07e-05	466	202	16	GSM777050_500
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDE10A CSMD2 DYSF HMCN2 FCGR3B ABCC8 FFAR2 AOX1 PTPRT NAMPT HMCN1	2.31e-09	195	209	11	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDE10A CSMD2 DYSF HMCN2 FCGR3B ABCC8 FFAR2 AOX1 PTPRT NAMPT HMCN1	2.31e-09	195	209	11	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 TLR7 GCNT2 DOCK5 GK PLD4 FLNA LRP1 HERC4 CX3CR1	7.49e-09	168	209	10	c0aef5947b1d7e2c81a7481c509feda1687fcd7f
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 TLR7 GCNT2 DOCK5 GK PLD4 FLNA LRP1 HERC4 CX3CR1	7.49e-09	168	209	10	c861f80aa12caf54a94d93e38539ff41dc5227a6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 RGS22 FAT1 PCDH15 PKHD1 USH2A SDK1 PIEZO2 HMCN1 PLCH1	1.79e-08	184	209	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 RGS22 FAT1 PCDH15 PKHD1 USH2A SDK1 PIEZO2 HMCN1 PLCH1	1.79e-08	184	209	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 RGS22 FAT1 PCDH15 PKHD1 USH2A SDK1 PIEZO2 HMCN1 PLCH1	1.79e-08	184	209	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS8 GCNT2 TMEM62 PTPRF PKHD1 MOCOS AP1M2 IGFBP7 PLCH1 MYBL2	2.67e-08	192	209	10	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	distal-2-Hematologic-Myeloid_Dendritic_Type_2\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LDHAL6A GRAMD4 DOCK5 SACS KCNMB1 PLD4 CD200R1 MB21D2 CHEK2 CACNA2D3	2.95e-08	194	209	10	6881cfe12837a32e598535a564e4c31d4846167b
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|Mesenchymal_cells / Lineage and Cell class	IGSF10 HMCN2 SMPDL3A SLC66A3 ADAMTS2 PIEZO2 IGFBP7 LRP1 CLEC3B FUCA1	3.41e-08	197	209	10	cb321836980e7b4efbb9284c6af7ccd34079d2be
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EXTL1 SOX8 CSMD2 ABCC8 DHCR7 PCDH15 PTPRT SLC6A1 ATRNL1 LRP1	3.75e-08	199	209	10	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EXTL1 SOX8 CSMD2 ABCC8 DHCR7 PCDH15 PTPRT SLC6A1 ATRNL1 LRP1	3.75e-08	199	209	10	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EXTL1 SOX8 CSMD2 ABCC8 DHCR7 PCDH15 PTPRT SLC6A1 ATRNL1 LRP1	3.75e-08	199	209	10	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX9 DYSF SACS WASHC5 SLC25A29 GRIN3A WWP2 TGDS UEVLD	1.50e-07	175	209	9	a5db428b078938627e61b7e944c1e0c1d61ac2da
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX9 DYSF SACS WASHC5 SLC25A29 GRIN3A WWP2 TGDS UEVLD	1.50e-07	175	209	9	8b498eea1ec1c1f27b171025c3d08adf3687bafc
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PRSS8 GCNT2 PTPRF PKHD1 TSPEAR AP1M2 TDRD7 SLC15A1 PLCH1	2.19e-07	183	209	9	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	facs-Lung-EPCAM-24m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS22 DRC1 CFAP65 PTPRF PIGR DBNL AP1M2 LDHB GRHL3	2.75e-07	188	209	9	c2ef270f691d367b1621d48f0771267cefe1630d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GCNT2 FAT1 PCDH15 GRIN3A ALK OVOS2 PTCHD4 PTPRT SLC6A1	2.88e-07	189	209	9	f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GCNT2 FAT1 PCDH15 GRIN3A ALK OVOS2 PTCHD4 PTPRT SLC6A1	3.15e-07	191	209	9	fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE10A IGSF10 PCDH15 SDK1 ADAMTS2 TNC AOX1 PIEZO2 LRP1	3.29e-07	192	209	9	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 PCDH15 SDK1 ADAMTS2 TNC AOX1 PIEZO2 CHEK2 LRP1	3.29e-07	192	209	9	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS8 GCNT2 TMEM62 PTPRF PKHD1 AP1M2 NSUN7 IGFBP7 PLCH1	3.29e-07	192	209	9	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE10A IGSF10 PCDH15 SDK1 ADAMTS2 TNC AOX1 PIEZO2 LRP1	3.59e-07	194	209	9	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 PCDH15 SDK1 ADAMTS2 TNC AOX1 PIEZO2 CHEK2 LRP1	3.59e-07	194	209	9	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PDE10A TMEM132B FZD4 ABCC9 SLC6A1 PIEZO2 HMCN1 TNN CLEC3B	3.75e-07	195	209	9	22a481927147ec4ae9d59e6af7c87df0e9cb51e4
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 FAT1 PCDH15 ABCC9 PIEZO2 HMCN1 IGFBP7 LRP1 CLEC3B	3.91e-07	196	209	9	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 FAT1 PCDH15 ABCC9 PIEZO2 HMCN1 IGFBP7 LRP1 CLEC3B	3.91e-07	196	209	9	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	wk_15-18-Hematologic-Myeloid-SPP1+_Mac\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO7A STYXL2 TLR7 SLC15A3 AP1B1 PLD4 MRC1 CD200R1 LPAR6	4.44e-07	199	209	9	c7fc2ac1601346aac71e7620a8a440fde8d92dbd
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	GCNT2 SMYD4 FAT1 GK PTPRF PIGR C5 ARSJ TGDS	4.63e-07	200	209	9	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	E16.5-samps-Myeloid\|E16.5-samps / Age Group, Lineage, Cell class and subclass	TLR7 SLC15A3 GVINP1 FCGR3B PLD4 MRC1 CD200R1 CX3CR1	7.63e-07	156	209	8	c7c73cef5700b0ae75280e62c94728434c712537
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 SYCP1 PKHD1 USH2A PTCHD4 PTPRT HMCN1 CACNA2D3	9.24e-07	160	209	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 SYCP1 PKHD1 USH2A PTCHD4 PTPRT HMCN1 CACNA2D3	9.24e-07	160	209	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	PND01-03-samps-Myeloid-Macrophage-macrophage-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	TLR7 SLC15A3 FCGR3B PLD4 MRC1 MINK1 CD200R1 CNDP2	9.68e-07	161	209	8	5925ee646aa040550e3f8a164a13c8a5c0353319
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDM1 TLR7 DOCK5 FCGR3B PLD4 FLNA LDHAL6B CX3CR1	1.11e-06	164	209	8	15d52666e5150e7c34b1f641a937fb2d5e8aaf8a
ToppCell	facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDM1 TLR7 DOCK5 FCGR3B PLD4 FLNA LDHAL6B CX3CR1	1.11e-06	164	209	8	d622f0d8d8bad48dfdf160ec63c545df192637a9
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 TLR7 DOCK5 GK SMPDL3A PLD4 FLNA CX3CR1	1.33e-06	168	209	8	4b5be7c6662eceddf90a65015f12908278d1664e
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 TLR7 DOCK5 GK SMPDL3A PLD4 FLNA CX3CR1	1.33e-06	168	209	8	689c41f6e9f65381570991cc311cba49a57ec955
ToppCell	droplet-Lung-nan-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDM1 TLR7 GCNT2 DOCK5 GK PLD4 FLNA CX3CR1	1.39e-06	169	209	8	ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b
ToppCell	droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDM1 TLR7 GCNT2 DOCK5 GK PLD4 FLNA CX3CR1	1.39e-06	169	209	8	c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 CNTN6 PCDH15 PKHD1 C4B USH2A PTPRT PLCH1	1.39e-06	169	209	8	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	facs-BAT-Fat-18m-Myeloid-nan\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLR7 FCGR3B SMPDL3A PLD4 FLNA RNPEP LRP1 CX3CR1	1.59e-06	172	209	8	36fe66a8c0aecee7a19269be23210c0ed7abb155
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A CLEC16A RAD54L MRC1 CD200R1 LIG1 GMCL1 UEVLD	2.06e-06	178	209	8	de6cd81e6d58e7687386df163471bf1901b9c0aa
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	STYXL2 SLC15A3 CD101 MRC1 FLNA RNPEP LRP1 GPA33	2.06e-06	178	209	8	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A TLR7 SLC15A3 SMPDL3A PLD4 MRC1 FFAR2 CD47	2.23e-06	180	209	8	cc31d2cd06161300b91b17a67bb432b75f0d719b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GCNT2 FAT1 KCNMB1 GRIN3A ALK DNAH2 OVOS2 SLC6A1	2.23e-06	180	209	8	392bc71a69653ba12de31bed4e9357f181094641
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 PCDH15 SDK1 ARSJ ADAMTS2 TNC PIEZO2 LRP1	2.23e-06	180	209	8	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A TLR7 SLC15A3 SMPDL3A PLD4 MRC1 FFAR2 CD47	2.43e-06	182	209	8	94d061b7b5ebbfc564c644bc8b2d52341927145d
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SOX9 TM7SF3 CNTN6 C4A C5 ARSJ HMCN1 IGFBP7	2.53e-06	183	209	8	ec2af3402b51f11466d2a5783a6b33746b6a7fc9
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX9 PTPRF PIGR EBPL C5 TSPEAR AP1M2 CACNA2D3	2.74e-06	185	209	8	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A SLC15A3 MRC1 FFAR2 CD200R1 NAMPT LRP1 CNDP2	2.85e-06	186	209	8	7950e03ea080238c168b9d807e217f459acdfb28
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN6 PTPRF PKHD1 C5 MOCOS ARSJ TRIM71 CACNA2D3	2.85e-06	186	209	8	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GCNT2 FAT1 PCDH15 GRIN3A ALK PTCHD4 PTPRT SLC6A1	2.85e-06	186	209	8	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRSS8 GCNT2 CNTN6 PTPRF PKHD1 TRIM71 NSUN7 PLCH1	3.09e-06	188	209	8	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS8 GCNT2 CNTN6 PTPRF SULT1C2 PKHD1 TRIM71 PLCH1	3.09e-06	188	209	8	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 GRIN3A SDK1 ALK CA13 PTCHD4 PTPRT SLC6A1	3.09e-06	188	209	8	3139540a656c0436b2123ea50741ff8d00112165
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 PCDH15 SDK1 TNC AOX1 PIEZO2 CHEK2 LRP1	3.21e-06	189	209	8	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	STYXL2 TLR7 CCL18 MRC1 FLNA MINK1 LRP1 GPA33	3.21e-06	189	209	8	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE10A PCDH15 SDK1 TNC AOX1 PIEZO2 CHEK2 LRP1	3.21e-06	189	209	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE10A PCDH15 SDK1 ADAMTS2 TNC AOX1 PIEZO2 LRP1	3.34e-06	190	209	8	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 PCDH15 SDK1 TNC AOX1 PIEZO2 CHEK2 LRP1	3.34e-06	190	209	8	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TES PFN1 TTC3 IL23R ADAMTS2 LDHA CD200R1 SLC15A1	3.34e-06	190	209	8	d85b34d19af43d83ebe728f3c7bbefd3792df4a6
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE10A IGSF10 PCDH15 SDK1 TNC AOX1 PIEZO2 LRP1	3.47e-06	191	209	8	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GCNT2 FAT1 PCDH15 GRIN3A ALK PTCHD4 PTPRT SLC6A1	3.47e-06	191	209	8	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	PDE10A ARSJ ADAMTS2 TNC ABCC9 PIEZO2 MB21D2 IGFBP7	3.47e-06	191	209	8	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDH15 SDK1 ADAMTS2 TNC AOX1 PIEZO2 IGFBP7 LRP1	3.61e-06	192	209	8	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 PCDH15 SDK1 TNC AOX1 PIEZO2 CHEK2 LRP1	3.61e-06	192	209	8	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE10A PCDH15 SDK1 TNC AOX1 PIEZO2 IGFBP7 LRP1	3.61e-06	192	209	8	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE10A IGSF10 PCDH15 SDK1 ADAMTS2 TNC PIEZO2 LRP1	3.61e-06	192	209	8	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS8 TES GCNT2 PTPRF PKHD1 AP1M2 IGFBP7 PLCH1	3.75e-06	193	209	8	979980369d2dbee9dc4770d72b93037abd7786eb
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS8 TES GCNT2 TMEM62 PTPRF PKHD1 AP1M2 PLCH1	3.75e-06	193	209	8	ab78fb1603ea6f720ba2d30148fe65dccf271fe1
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 PCDH15 SDK1 ADAMTS2 TNC AOX1 PIEZO2 LRP1	3.75e-06	193	209	8	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	10x5'v1-week_17-19-Myeloid_DC-DC-DC2\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PFN1 KCNMB1 PLD4 CD200R1 IGFBP7 CNDP2 CX3CR1 CACNA2D3	3.89e-06	194	209	8	833c695779edc94690b08814b0dedcf00ae082cd
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	IGSF10 PCDH15 SDK1 ADAMTS2 AOX1 PIEZO2 HMCN1 CACNA2D3	4.04e-06	195	209	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_2-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LDHAL6A GRAMD4 DOCK5 SACS KCNMB1 PLD4 MB21D2 CACNA2D3	4.04e-06	195	209	8	7606b8b40e704bb5447ac57ccf8698794e9c7890
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRSS8 GCNT2 CNTN6 PTPRF PKHD1 C5 AP1M2 PLCH1	4.04e-06	195	209	8	d67a2b489c29bfd575751c13d2a5b1efdec5240a
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SMYD4 PTPRF PIGR EBPL C5 ARSJ AP1M2 TGDS	4.36e-06	197	209	8	1638959d7aecb9fc5285eb7e4a3103ca437989e2
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells\|LPS_only / Treatment groups by lineage, cell group, cell type	TLR7 GCNT2 CD101 PLD4 MRC1 SEMA7A NLRP1 CD200R1	4.36e-06	197	209	8	59ddd8ff7dddf3747b988374e1a4d80959db803e
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PDE10A FZD4 MRC1 ABCC9 PIEZO2 HMCN1 IGFBP7 LPAR6	4.36e-06	197	209	8	4e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RGS22 CFAP65 RHPN1 LMLN MDH1B DYNC2H1 DNAH2 PTPRT	4.36e-06	197	209	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO7A RGS22 SOX8 PDE10A PKHD1 CACNA2D4 IGFBP7 EIF3I	4.36e-06	197	209	8	6806ec223e542f0475303698eb78c1cc527f5c6b
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SMYD4 PTPRF PIGR EBPL C5 ARSJ AP1M2 TGDS	4.36e-06	197	209	8	ad6f047d003c08413264f39a30ba0f7639a257cd
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GCNT2 SMYD4 FAT1 GK PTPRF PIGR C5 ARSJ	4.53e-06	198	209	8	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SMYD4 PTPRF PIGR EBPL C5 ARSJ AP1M2 TGDS	4.53e-06	198	209	8	aa80315395cb5dffc25927c8a77cd2037aea8772
ToppCell	wk_20-22-Hematologic-Myeloid-SPP1+_Mac\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MYO7A TLR7 SLC15A3 AP1B1 PLD4 MRC1 CD200R1 LPAR6	4.70e-06	199	209	8	7c19f1b1f4369edd035ca9cdcf4e653771fc4648
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	IGSF10 SDK1 DYNC2H1 TNC AOX1 IGFBP7 CHEK2 LRP1	4.87e-06	200	209	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TMEM132B FZD4 MRC1 ABCC9 PIEZO2 IGFBP7 LPAR6 CLEC3B	4.87e-06	200	209	8	ae429f2de652cc1976e63644781197e9ce0e70c8
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT1 FLNA TNC ABCC9 SLC6A1 IGFBP7 ATRNL1 LRP1	4.87e-06	200	209	8	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Myeloid-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A OTOF FCGR3B PLD4 MRC1 RTN4IP1 BAHD1	5.93e-06	146	209	7	69cbe8d4772f8e46a5e1a1cdca0e370308a97b4f
ToppCell	COVID-19_Mild-PLT_3\|World / Disease Group and Platelet Clusters	PDE10A PKHD1 C4A FLNA DYNC2H1 DBNL GPA33	6.20e-06	147	209	7	9d3271aa735ddb6f32ab864d7afcfb0f8754383b
ToppCell	facs-Pancreas-Exocrine-3m-Hematologic-leukocyte\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLR7 SLC15A3 FCGR3B PLD4 MRC1 CD200R1 CX3CR1	6.48e-06	148	209	7	bbf4933582b50b3412c805de5ed137107c996236
ToppCell	facs-Pancreas-Exocrine-3m-Hematologic\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLR7 SLC15A3 FCGR3B PLD4 MRC1 CD200R1 CX3CR1	6.48e-06	148	209	7	79e376503a3f9504a1ec5af4a60a09cc80e19059
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CSMD2 TMEM132B PCDH15 USH2A ALK PTPRT ATRNL1	6.48e-06	148	209	7	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	LPS_only-Myeloid-Dendritic_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TLR7 PLD4 MRC1 SEMA7A NLRP1 CD200R1 GMCL2	6.48e-06	148	209	7	cb9365663f9cba35d47b5dd9079f42e88b70d915
ToppCell	facs-Pancreas-Exocrine-3m-Hematologic-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLR7 SLC15A3 FCGR3B PLD4 MRC1 CD200R1 CX3CR1	6.48e-06	148	209	7	6543860e3207a7de92a35bb6004be51287582f7a
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA12 FCGR3B SYCP1 PCDH15 IL23R NAMPT ATRNL1	6.78e-06	149	209	7	c5eedb54ef2e0f131aa6730612c921bc19479632
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA12 FCGR3B SYCP1 PCDH15 IL23R NAMPT ATRNL1	6.78e-06	149	209	7	a22417286de8606f0cc94f86b70bce17aeefb9c2
ToppCell	droplet-Bladder-nan-3m-Hematologic-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC15A3 OTOF FCGR3B PLD4 MRC1 NLRP1 CD200R1	7.40e-06	151	209	7	a7b1a60d68f0ed17022fe4c97af64f9f08d39fa3
ToppCell	droplet-Fat-Mat-18m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEP1B PTPRH SULT1C2 PIGR PKHD1 PPFIA3 GPA33	9.15e-06	156	209	7	0d79b4172896574b00faf00e87254f68d76f5512
ToppCell	droplet-Fat-Mat-18m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEP1B PTPRH SULT1C2 PIGR PKHD1 PPFIA3 GPA33	9.15e-06	156	209	7	cfd7f56f3155db677684827607e9008e975dbe70
ToppCell	droplet-Fat-Mat-18m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEP1B PTPRH SULT1C2 PIGR PKHD1 PPFIA3 GPA33	9.15e-06	156	209	7	f09150aacb6121f913648ed3918f9cd4f22c61f2
Drug	sodium oxamate	LDHAL6A LDHAL6B LDHA LDHB PCSK7	1.44e-08	10	207	5	CID000005242
Drug	bis-NAD	LDHAL6A DLD LDHAL6B LDHA LDHB	1.44e-08	10	207	5	CID003081557
Drug	polyvinylpyridine-N-oxide	LDHAL6A DLD LDHAL6B LDHA LDHB	2.62e-08	11	207	5	CID000024772
Drug	spirobishexahydropyrimidine	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000100750
Drug	AC1O5TJF	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID006440410
Drug	1,4-diethoxybutane	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000232578
Drug	S-lac-NAD	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000194292
Drug	sorbarin	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID009824100
Drug	AC1O5ZB9	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID006443605
Drug	AC1L49DG	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000152931
Drug	N-trifluoroacetyl-glycine	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000136227
Drug	acetylphosphonic acid	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000081311
Drug	NSC-60195	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000020481
Drug	ethyl gossypol	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000374353
Drug	oxyayanin A	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID005281676
Drug	B-HAD	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000131338
Drug	SQ 31,486	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000130015
Drug	BMS-188107	LDHAL6A LDHAL6B LDHA LDHB	3.30e-08	5	207	4	CID000192297
Drug	3-mercaptolactic acid	LDHAL6A HAO1 LDHAL6B LDHA LDHB	7.18e-08	13	207	5	CID000160645
Drug	2-oxohexanoate	LDHAL6A DLD LDHAL6B LDHA LDHB	7.18e-08	13	207	5	CID000159664
Drug	BL-443	LDHAL6A LDHAL6B LDHA LDHB	9.82e-08	6	207	4	CID000054436
Drug	dansyl-L-lysine	LDHAL6A LDHAL6B LDHA LDHB	9.82e-08	6	207	4	CID000598797
Drug	I 65	LDHAL6A LDHAL6B LDHA LDHB	9.82e-08	6	207	4	CID000149068
Drug	D 701	LDHAL6A LDHAL6B LDHA LDHB	9.82e-08	6	207	4	CID003051460
Drug	2,3-dihydroxy-1-naphthoic acid	LDHAL6A LDHAL6B LDHA LDHB	9.82e-08	6	207	4	CID000028002
Drug	AC1L24G8	LDHAL6A LDHAL6B LDHA LDHB	9.82e-08	6	207	4	CID000066023
Drug	oxymethacil	LDHAL6A LDHAL6B LDHA LDHB	9.82e-08	6	207	4	CID000096369
Drug	SQ 32,926	LDHAL6A LDHAL6B LDHA LDHB	9.82e-08	6	207	4	CID000131363
Drug	scymnol	LDHAL6A LDHAL6B NLRP1 LDHA LDHB	1.11e-07	14	207	5	CID000165531
Drug	3-mercaptopyruvate	LDHAL6A HAO1 DLD MOCOS LDHAL6B LDHA LDHB	2.14e-07	47	207	7	CID000000098
Drug	AC1O7170	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID006540699
Drug	BS35	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID000029316
Drug	BS36	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID000029308
Drug	pentabromoacetone	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID000065579
Drug	methyl-4-hydroxy-3-nitrobenzimidate	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID005492576
Drug	gossylic iminolactone	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID005479302
Drug	N-acetyl-9-O-lactylneuraminic acid	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID000191486
Drug	sodium glycolate	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID000517347
Drug	AC1NSM0G	LDHAL6A LDHAL6B LDHA LDHB	2.27e-07	7	207	4	CID005365671
Drug	p-(phenoxypropoxy)aniline	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID000423258
Drug	BS37	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID000027925
Drug	U75412E	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID003035460
Drug	AC1Q3O0A	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID000060880
Drug	UR-12633	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID000128030
Drug	2-methyl-2-pentenoate	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID000018458
Drug	AC1L4GHU	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID000156607
Drug	N-dodecyl morpholine	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID000073764
Drug	S-(2-chloroethyl)-L-cysteine	LDHAL6A LDHAL6B LDHA LDHB	4.52e-07	8	207	4	CID000034229
Drug	N-(3,5-dichlorophenyl)-2-hydroxysuccinimide	LDHAL6A LDHAL6B NLRP1 LDHA LDHB	4.61e-07	18	207	5	CID000114902
Drug	bimakalim	LDHAL6A ABCC8 LDHAL6B LDHA LDHB	6.20e-07	19	207	5	CID000060674
Drug	benzamyl	LDHAL6A LDHAL6B LDHA LDHB	8.07e-07	9	207	4	CID000160884
Drug	Bcdfg	LDHAL6A LDHAL6B LDHA LDHB	8.07e-07	9	207	4	CID003036106
Drug	N-acetyl-ala-ala-ala-methyl ester	LDHAL6A LDHAL6B LDHA LDHB	8.07e-07	9	207	4	CID000100120
Drug	5-hydroxydecanoate	LDHAL6A ABCC8 LDHAL6B ABCC9 NLRP1 LDHA LDHB PCSK7	1.29e-06	87	207	8	CID000001824
Drug	hydroxyisonobilin	LDHAL6A LDHAL6B LDHA LDHB	1.34e-06	10	207	4	CID006438562
Drug	pyridinophane cryptand	LDHAL6A LDHAL6B LDHA LDHB	1.34e-06	10	207	4	CID006454246
Drug	FK3311	LDHAL6A LDHAL6B LDHA LDHB	1.34e-06	10	207	4	CID000164009
Drug	2-keto-4-mercaptobutyric acid	LDHAL6A LDHAL6B LDHA LDHB	1.34e-06	10	207	4	CID000151198
Drug	mivazerol	LDHAL6A LDHAL6B LDHA LDHB	1.34e-06	10	207	4	CID000060783
Drug	phosphoenolthiopyruvate	LDHAL6A LDHAL6B LDHA LDHB	1.34e-06	10	207	4	CID000194910
Drug	2 MAC	LDHAL6A LDHAL6B NLRP1 LDHA LDHB	1.37e-06	22	207	5	CID000005624
Drug	HMR 1098	LDHAL6A ABCC8 LDHAL6B LDHA LDHB	1.37e-06	22	207	5	CID003037766
Drug	alpha-ketovalerate	LDHAL6A ABCC8 LDHAL6B LDHA LDHB	1.74e-06	23	207	5	CID000074563
Drug	AcPyAD	LDHAL6A DLD LDHAL6B LDHA LDHB	1.74e-06	23	207	5	CID000002010
Drug	fluoropyruvate	LDHAL6A DLD LDHAL6B LDHA LDHB	1.74e-06	23	207	5	CID000067946
Drug	NSC44567	LDHAL6A C4A LDHAL6B LDHA LDHB	1.74e-06	23	207	5	CID000239473
Drug	hexandiol	LDHAL6A LDHAL6B LDHA LDHB	2.08e-06	11	207	4	CID000147023
Drug	5-ethylphenazin-5-ium	LDHAL6A LDHAL6B LDHA LDHB	2.08e-06	11	207	4	CID000082689
Drug	hydrazinium nitrate	LDHAL6A LDHAL6B LDHA LDHB	2.08e-06	11	207	4	CID000166817
Drug	2-acetolactate	LDHAL6A DLD LDHAL6B LDHA LDHB	2.19e-06	24	207	5	CID000000022
Drug	Primal	LDHAL6A CYTH2 LDHAL6B LDHA LDHB FUCA1	2.42e-06	43	207	6	CID001549157
Drug	ox-Q	LDHAL6A LDHA LDHB	2.94e-06	4	207	3	CID000448650
Drug	LG61	LDHAL6A LDHAL6B LDHA LDHB	3.10e-06	12	207	4	CID000520177
Drug	U74500A	LDHAL6A LDHAL6B LDHA LDHB	3.10e-06	12	207	4	CID000107964
Drug	2,3-butanediol	LDHAL6A GK GK2 LDHAL6B LDHA LDHB	3.63e-06	46	207	6	CID000000262
Drug	hydroxypyruvate	LDHAL6A HAO1 DLD LDHAL6B LDHA LDHB	3.63e-06	46	207	6	CID000000964
Drug	l 3000	LDHAL6A LDHAL6B LDHA LDHB RNPEP	4.06e-06	27	207	5	CID000102475
Drug	ethidium homodimer	TES LDHAL6A LDHAL6B LDHA LDHB	4.06e-06	27	207	5	CID004072365
Drug	diphenaldehyde	LDHAL6A LDHAL6B LDHA LDHB	4.45e-06	13	207	4	CID000014585
Drug	T 514	LDHAL6A LDHAL6B LDHA LDHB	4.45e-06	13	207	4	CID000114820
Drug	glyoxylate	LDHAL6A HAO1 FZR1 GK GK2 EBPL DLD LDHAL6B LDHA LDHB	5.08e-06	176	207	10	CID000000760
Drug	HgCl	LDHAL6A CYTH2 HAO1 LDHAL6B LDHA LDHB	5.30e-06	49	207	6	CID000024182
Drug	beryllium nitrate	LDHAL6A LDHAL6B LDHA LDHB	6.19e-06	14	207	4	CID000026126
Drug	AC1L3P2T	LDHAL6A LDHAL6B LDHA LDHB	6.19e-06	14	207	4	CID000119585
Drug	N,N'-diphenyl-p-phenylenediamine	LDHAL6A LDHAL6B LDHA LDHB CHEK2	7.01e-06	30	207	5	CID000006319
Drug	nisoldipine	LDHAL6A ITPR1 LDHAL6B LDHA LDHB CACNA2D4 CACNA2D3	7.10e-06	78	207	7	CID000004499
Drug	C4H3NO4	LDHAL6A LDHA LDHB	7.31e-06	5	207	3	CID000448651
Drug	Ac-YVAD-Amc	LDHAL6A LDHAL6B LDHA LDHB	8.38e-06	15	207	4	CID000004337
Drug	2-bromohydroquinone	LDHAL6A LDHAL6B LDHA LDHB	8.38e-06	15	207	4	CID000068502
Drug	H2O2	LDHAL6A ACTBL2 CHEK1 HAO1 ITPR1 DOCK5 GK FCGR3B ABCC8 DLD GNB2 PLD4 AOX1 LDHAL6B TSPEAR ABCC9 NLRP1 LDHA LDHB NAMPT CSK PRKACA PRKACB CHEK2 PCSK7 PLCH1 MYBL2	1.02e-05	1183	207	27	CID000000784
Drug	potassium citrate	LDHAL6A LDHAL6B LDHA LDHB	1.11e-05	16	207	4	CID000013344
Drug	1-methoxy-5-methylphenazine	LDHAL6A LDHAL6B LDHA LDHB	1.11e-05	16	207	4	CID000127832
Drug	tripotassium citrate monohydrate	LDHAL6A LDHAL6B LDHA LDHB	1.11e-05	16	207	4	CID002735208
Drug	cyclopentadienyl	MCHR2 HAO1 FAT1 C5 ADAMTS2	1.14e-05	33	207	5	CID000137443
Drug	lucigenin	LDHAL6A KCNMB1 LDHAL6B NLRP1 LDHA LDHB PCSK7	1.16e-05	84	207	7	CID000065099
Drug	LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A	MYO7A PDE10A SULT1C2 DCAF17 TMCO3 AP1M2 PHTF2 NLRP1 EFNB2 L3MBTL1	1.37e-05	197	207	10	2676_UP
Drug	triazin-1-ium	LDHAL6A GK GK2 DLD LDHA LDHB	1.43e-05	58	207	6	CID000123047
Drug	Calpain Inhibitor Vi	LDHAL6A LDHAL6B LDHA LDHB	1.44e-05	17	207	4	CID009885817
Drug	luminol	LDHAL6A HAO1 FCGR3B LDHAL6B NLRP1 LDHA LDHB	1.47e-05	87	207	7	CID000010638
Drug	caffeine	LDHAL6A CHEK1 PDE10A ITPR1 SMPDL3A WWP2 LDHAL6B NLRP1 LDHA LDHB CACNA2D4 LPAR6 PRKACA PRKACB CHEK2 PLCH1 CACNA2D3	1.64e-05	562	207	17	CID000002519
Disease	disease of metabolism (implicated_via_orthology)	LDHAL6A DLD LDHAL6B LDHA LDHB	2.94e-07	21	206	5	DOID:0014667 (implicated_via_orthology)
Disease	Usher Syndrome	MYO7A PCDH15 PLD4	1.33e-06	4	206	3	C0271097
Disease	Usher Syndrome, Type II	MYO7A PCDH15 USH2A	3.32e-06	5	206	3	C1568249
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	DYSF OTOF FER1L5	1.15e-05	7	206	3	DOID:11724 (implicated_via_orthology)
Disease	Breast Cancer, Familial	CHEK1 RINT1 RAD54L CHEK2	5.48e-05	30	206	4	C0346153
Disease	Lupus Erythematosus, Systemic	FCGR3B C4A C4B CLEC16A CSK	1.42e-04	71	206	5	C0024141
Disease	Usher syndrome type 2	MYO7A USH2A	1.45e-04	3	206	2	C0339534
Disease	X-12026 measurement	MOCOS AOX1	1.45e-04	3	206	2	EFO_0800700
Disease	glycerol kinase deficiency (implicated_via_orthology)	GK GK2	1.45e-04	3	206	2	DOID:0060363 (implicated_via_orthology)
Disease	Bipolar Disorder	MCHR2 PDE10A CNTN6 ITPR1 FZD4 NDST3 ADRA2C GRIN3A GNB3 DBNL LDHA CD47	1.45e-04	477	206	12	C0005586
Disease	Antibody Deficiency Syndrome	C4A C5 EPG5	2.12e-04	17	206	3	C0003257
Disease	systemic lupus erythematosus (implicated_via_orthology)	TLR7 C4A C4B PLD4	2.30e-04	43	206	4	DOID:9074 (implicated_via_orthology)
Disease	autosomal recessive congenital ichthyosis 4B (implicated_via_orthology)	PRSS8 ABCA12	2.88e-04	4	206	2	DOID:0060713 (implicated_via_orthology)
Disease	amino acid metabolic disorder (implicated_via_orthology)	TARS1 TARS3	2.88e-04	4	206	2	DOID:9252 (implicated_via_orthology)
Disease	Usher syndrome (is_implicated_in)	MYO7A USH2A	2.88e-04	4	206	2	DOID:0050439 (is_implicated_in)
Disease	Polyploidy	CHEK1 FZR1	2.88e-04	4	206	2	C0032578
Disease	Colorectal Carcinoma	ABCA12 FZD4 NDST3 FAT1 SACS ABCC8 PKHD1 TSPEAR PTPRT LIG1 GMCL2 NAMPT CHEK2 LRP1	4.49e-04	702	206	14	C0009402
Disease	ascending aortic diameter	ABCC8 KCNMB1 WWP2 ABCC9 PIEZO2 HMCN1	4.65e-04	140	206	6	EFO_0021787
Disease	Usher syndrome, type 1A	MYO7A PCDH15	4.78e-04	5	206	2	C2931205
Disease	USHER SYNDROME, TYPE IB (disorder)	MYO7A PCDH15	4.78e-04	5	206	2	C1848638
Disease	USHER SYNDROME, TYPE IA, FORMERLY	MYO7A PCDH15	4.78e-04	5	206	2	C1848639
Disease	USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY	MYO7A PCDH15	4.78e-04	5	206	2	C1848640
Disease	Usher syndrome type 1	MYO7A PCDH15	4.78e-04	5	206	2	cv:C1568247
Disease	Immunologic Deficiency Syndromes	C4A C5 EPG5	5.36e-04	23	206	3	C0021051
Disease	Usher Syndrome, Type I	MYO7A PCDH15	7.14e-04	6	206	2	C1568247
Disease	congestive heart failure (is_implicated_in)	ADRA2C GNB1 PRKACA	8.67e-04	27	206	3	DOID:6000 (is_implicated_in)
Disease	azoospermia (implicated_via_orthology)	NDST3 PTPRF TDRKH	8.67e-04	27	206	3	DOID:14227 (implicated_via_orthology)
Disease	anterior thigh muscle fat infiltration measurement	DYSF HMCN2 EBPL	9.66e-04	28	206	3	EFO_0020936
Disease	Hereditary retinal dystrophy	MYO7A PCDH15	9.95e-04	7	206	2	C0154860
Disease	drug use measurement, quality of life during menstruation measurement	SYCP1 SDK1	9.95e-04	7	206	2	EFO_0007010, EFO_0009366
Disease	Usher syndrome	MYO7A PCDH15	9.95e-04	7	206	2	cv:C0271097
Disease	Usher Syndrome, Type III	MYO7A PCDH15	9.95e-04	7	206	2	C1568248
Disease	Ciliopathies	MYO7A PCDH15 PKHD1 USH2A DYNC2H1	1.07e-03	110	206	5	C4277690
Disease	Liver Cirrhosis, Experimental	TES EXTL1 HAO1 PFN1 SLC15A3 DYSF FAT1 GK SULT2A1 PLD4 FLNA LDHB CD200R1 IGFBP7	1.15e-03	774	206	14	C0023893
Disease	Dermatitis, Allergic Contact	TLR7 FCGR3B MRC1 NAMPT	1.25e-03	67	206	4	C0162820
Disease	7-methylguanine measurement	MOCOS AOX1	1.32e-03	8	206	2	EFO_0021123
Disease	response to anti-thyroid drug, Drug-induced agranulocytosis	MOS MOCOS	1.32e-03	8	206	2	EFO_0007838, HP_0012235
Disease	Malignant neoplasm of breast	CHEK1 TTC3 DYSF CNTN6 OTOF ALK RAD54L FLNA DYNC2H1 B3GALNT2 LDHAL6B MANEA LDHB EPG5 IGFBP7 CHEK2 MAP3K13	1.50e-03	1074	206	17	C0006142
Disease	Complement deficiency disease	C4A C4B C5	1.57e-03	33	206	3	C0272242
Disease	plexin-B2 measurement	FCGR3B MRC1	1.69e-03	9	206	2	EFO_0021867
Disease	posterior thigh muscle fat infiltration measurement	DYSF HMCN2 EBPL	1.86e-03	35	206	3	EFO_0020934
Disease	Pleural Diseases	TNC CARD8	2.10e-03	10	206	2	C0032226
Disease	Unipolar Depression	SOX9 TLR7 GNB1 GNB3 LDHA LRP1 KYAT3	2.38e-03	259	206	7	C0041696
Disease	Nonsyndromic Deafness	MYO7A PCDH15 TNC TSPEAR	2.52e-03	81	206	4	C3711374
Disease	Graves' disease (is_implicated_in)	C4A C4B IL23R	2.55e-03	39	206	3	DOID:12361 (is_implicated_in)
Disease	pregnenetriol sulfate measurement	SULT2A1 UGT1A4	2.56e-03	11	206	2	EFO_0800586
Disease	Inherited neuropathies	ITPR1 SACS WASHC5	2.74e-03	40	206	3	C0598589
Disease	hyperinsulinism (is_implicated_in)	PTPRF ABCC8	3.06e-03	12	206	2	DOID:2018 (is_implicated_in)
Disease	anxiety disorder, stress-related disorder	SDK1 PTPRT	3.06e-03	12	206	2	EFO_0006788, EFO_0010098
Disease	pregnenetriol disulfate measurement	SULT2A1 UGT1A4	3.60e-03	13	206	2	EFO_0800587
Disease	esophagus squamous cell carcinoma (is_implicated_in)	FAT1 PTPRT EFNB2	3.83e-03	45	206	3	DOID:3748 (is_implicated_in)
Disease	Kartagener syndrome (implicated_via_orthology)	DRC1 AP1B1	4.18e-03	14	206	2	DOID:0050144 (implicated_via_orthology)
Disease	S-6-hydroxywarfarin measurement	SOX8 DYSF PCDH15 GRIN3A MOCOS MINK1 HMCN1 CD47	4.51e-03	368	206	8	EFO_0803326
Disease	Breast Carcinoma	CHEK1 ALK RAD54L FLNA DYNC2H1 LDHAL6B LDHB IGFBP7 CHEK2 MAP3K13	4.75e-03	538	206	10	C0678222
Disease	hearing impairment	MYO7A OTOF PCDH15 USH2A	5.00e-03	98	206	4	C1384666
Disease	sciatic neuropathy (biomarker_via_orthology)	ABCC8 ABCC9 LRP1 CX3CR1	5.18e-03	99	206	4	DOID:11446 (biomarker_via_orthology)
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO7A OTOF PCDH15	5.46e-03	51	206	3	cv:CN043650
Disease	X-21441 measurement	SULT2A1 UGT1A4	6.16e-03	17	206	2	EFO_0800814
Disease	Night blindness, congenital stationary	GNB3 CACNA2D4	6.16e-03	17	206	2	C0339535
Disease	complement factor H-related protein 3 measurement	PCDH15 USH2A SDK1 MANEA PTPRT	6.80e-03	169	206	5	EFO_0600056
Disease	Age-related macular degeneration	HMCN1 CX3CR1	6.89e-03	18	206	2	cv:C0242383

Protein segments in the cluster

Peptide	Gene	Start	Entry
PVLIRYVWTLNSTKF	TMEM62	616	Q0P6H9
KILEPGSWLENVESY	EPG5	261	Q9HCE0
KFRYLSWDTPQEVIA	DCAF17	151	Q5H9S7
TLWYAPLSLTNVDKV	ACOT7L	81	Q6ZUV0
SEESRPYTNKVITLW	CDK12	886	Q9NYV4
NWHIRAVTVYDKPAS	ALG1	206	Q9BT22
SAKYVPERNVVIWSI	AP1M2	331	Q9Y6Q5
AIEAVAISPWKTYQL	RNPEP	521	Q9H4A4
CDWKVTVSPDYVIAL	CSMD2	1471	Q7Z408
GSNTWVTYPEVLKEF	C2orf69	306	Q8N8R5
SLWDTSPSYIDKLVQ	CHEK1	326	O14757
QAPALWIETTAYALL	C4B	1256	P0C0L5
LTLKYPIEHGVVTNW	ACTBL2	66	Q562R1
TGVPANRTLAKVWYD	ABCA12	1916	Q86UK0
WSVTQAVEYNLKRTP	ADRA2C	151	P18825
DVLWYKLTPAVSTTI	GVINP1	2086	Q7Z2Y8
QPEITQKLYVALWAA	GRAMD4	331	Q6IC98
FVAVVWDKSSPVEAL	CIAPIN1	11	Q6FI81
SWQIPQKFIVDYSET	CCL18	36	P55774
LTIVAVTKDPNWYKA	CSK	36	P41240
VATLPFWTHYLINEK	CX3CR1	81	P49238
SVAYAAQKPWLLNAT	ABCC9	751	O60706
YWRLLSTDPVAAKEV	AP1B1	526	Q10567
VVHWNSDKYPSFVEA	CA13	121	Q8N1Q1
LPAVKATWLYGIQIT	DPY19L3	281	Q6ZPD9
TSGKYNFIPEVWAEV	CHEK2	441	O96017
PITRKAAQLYTLWVT	DHCR7	91	Q9UBM7
PSQYSAIKEEDLVVW	BPNT1	101	O95861
NISDPSKKSYVVQWL	ADAMTS2	1031	O95450
LVSVNIPYSRKWEFV	AOX1	411	Q06278
QDAVVPSEWLSSVYK	GMCL1	351	Q96IK5
VWNIKITSTEEYPHL	NDST3	441	O95803
VVSPSSLVKNWYNEV	RAD54L	216	Q92698
TTVLPLYQKSVWTQE	KCNMB1	36	Q16558
VSNPVDILTYVAWKI	LDHA	136	P00338
KIAPASQIDSAWIVY	ANAPC1	1146	Q9H1A4
VQAPVKLYSDWLSVG	PADI4	456	Q9UM07
NITVYDLGIPQKAAW	FAT1	791	Q14517
TDWIAIYQRKVEAPF	PRKACA	301	P17612
KRWVAVLSQDYPTLA	GNL2	266	Q13823
IIEAASNFRWYLPKV	FFAR2	66	O15552
NYPWDVAVNSEGKIL	TRIM71	701	Q2Q1W2
SKGLQWIIDTTIAYP	LPGAT1	246	Q92604
PTKVADWFYDSISIV	MB21D2	181	Q8IYB1
TTVVWDKITGEPLYN	GK3P	96	Q14409
TERVVIWPFSNKNYI	GPA33	66	Q99795
QEQVTPVKYARLWSE	ITPR1	796	Q14643
DPGTKVLLVSWTYQD	INTS11	566	Q5TA45
DLVASEVPWKYVINT	GCNT2	176	Q8N0V5
TVTWYKDGQPLVLAQ	HMCN2	3071	Q8NDA2
TKITWPNGLTLDYVT	LRP1	3186	Q07954
PETKEISWEQILAYG	PPFIA3	936	O75145
SGFYPEAINITWEKQ	NCR3LG1	166	Q68D85
KSVWLFNITADPYER	ARSJ	491	Q5FYB0
PVVTSKVYNAVANLW	SMPDL3A	161	Q92484
LWIFSPIEAKTYTVD	CFAP65	1371	Q6ZU64
AKLYAWVALQSLPEE	KIAA1109	3961	Q2LD37
SPQGLKVWVQDTSYL	LMLN	556	Q96KR4
NPWTKELEYIVSVNT	ARNTL2	456	Q8WYA1
LVSYADIDICPTNWK	CCNYL2	221	Q5T2Q4
KSIVLEPIYWNSSNS	EFNB2	26	P52799
RLVNAAKIWTSVPYL	PCSK7	471	Q16549
SNPVDILTYVAWKLS	LDHAL6B	186	Q9BYZ2
WESYLEEQKAITAPV	L3MBTL1	276	Q9Y468
LWPVTKLTANDIYAE	PDE10A	671	Q9Y233
PVTDAYWQILFSVLK	NLRP1	791	Q9C000
TVNEALIQKWLSYPS	HERC4	401	Q5GLZ8
WTYDSVKTPIQRAVQ	FAM47B	616	Q8NA70
LSWLYNDSPVKDEVV	FUCA1	246	P04066
AAYVAKAIDPSISWE	HAO1	206	Q9UJM8
LWEIENNPTVKASGY	HDGF	86	P51858
YQRQFVWKTSKETAP	MDM1	191	Q8TC05
KADARWVYFDPTIVS	EBPL	86	Q9BY08
QNYSKVLAEVNTSWP	CD200R1	36	Q8TD46
IWDSYTTNKVHAIPL	GNB2	81	P62879
VWDSYTTNKVHAIPL	GNB3	81	P16520
TAALKLVAEAFPWVS	MOCOS	121	Q96EN8
NFPEATWKTYLSRIV	LPAR6	171	P43657
PKDIWNVTGAQVYLS	IGFBP7	166	Q16270
IPDLTYASKIVQWLA	OVOS2	1201	Q6IE36
SKDSEYWQALTTVIP	DRC1	656	Q96MC2
YITKPEKWANLLTTS	MANEA	271	Q5SRI9
IVSILNPIYWTTAKE	HMCN1	4926	Q96RW7
NPIYWTTAKEIGEAV	HMCN1	4931	Q96RW7
HITAVFLTLYEWKSP	GRIN3A	686	Q8TCU5
GATYLWIKPNANSII	PTPRT	301	O14522
LVKFLESPWIVYVTQ	FADS2B	366	A8MWK0
DLEKTFQTYWVLGVP	PLD4	256	Q96BZ4
IPYKDVDSSAIIWGV	MAP3K13	351	O43283
SFILALPVWVYSKVI	MCHR2	161	Q969V1
PTIELSLKDNVDYWV	PCDH15	71	Q96QU1
YFHIAAWAIPAVKTI	FZD4	346	Q9ULV1
YTEHLAAVKAIAWSP	FZR1	351	Q9UM11
WKAAVSQYEKIIAPA	DYNC2H1	381	Q8NCM8
AAPLAAWVKANIQYS	DYNC2H1	3086	Q8NCM8
QPSVYWVLSDGTEVK	IGSF10	1871	Q6WRI0
AGYSDLKVPLTVTWQ	CD101	566	Q93033
AWKTYLENPLTAATK	GRHL3	31	Q8TE85
TDWIAIYQRKVEAPF	PRKACB	301	P22694
QPCWYETVKVSIAIE	DOCK5	506	Q9H7D0
TTVIWDKLTGEPLYN	GK2	96	Q14410
IWDSYTTNKVHAIPL	GNB1	81	P62873
KDPAIVNGVYWSESL	CACNA2D3	181	Q8IZS8
WYIQAATSPKDVVIL	CACNA2D3	246	Q8IZS8
NDKNRTFSVWYVPEV	FLNA	336	P21333
WYIQAATSPKDIVIL	CACNA2D4	281	Q7Z3S7
LSSDVTHYVIPDWKV	DIS3L	51	Q8TF46
ALFPQWKSTHYDVVV	B3GALNT2	41	Q8NCR0
TWGQEQTYVISAPKI	C5	16	P01031
FTVAKDPIVNVWYSV	EIF3I	26	Q13347
EWIKSIQAAVSVDPF	CYTH2	366	Q99418
INATVPKTIIYWDSQ	IL23R	231	Q5VWK5
ELIDKSTNRYSVWFP	CARD8	171	Q9Y2G2
TTVVWDKITGEPLYN	GK	96	P32189
TSTPYVAKISALWEN	BAHD1	641	Q8TBE0
VYVSNFSWPIKIQIA	ATRNL1	1206	Q5VV63
KTYNATVVGLSPWVE	CNTN6	656	Q9UQ52
SVIYTHPEVAWVGKS	DLD	391	P09622
IVSWLSTYPVDVVKS	SLC25A29	201	Q8N8R3
APSYIKDVIIWGNIS	MDH1B	301	Q5I0G3
GEIPYKDVDSSAIIW	MAP3K12	306	Q12852
AVVFLEPQWYSVLEK	FCGR3B	26	O75015
EPQWYSVLEKDSVTL	FCGR3B	31	O75015
TLASLKPWTQYAVFV	INSRR	561	P14616
KPWTQYAVFVRAITL	INSRR	566	P14616
NPYRAKVLIAVSWAT	GPR63	191	Q9BZJ6
VVSNPVDILTYVTWK	LDHB	136	P07195
TWKPSTVYLFNLAVA	HCAR1	46	Q9BXC0
IIELKYRVVSWFSPN	CD47	126	Q08722
VWEVKCADLSLSPIY	LIG1	841	P18858
IAKTWDVTQLDIVPY	DNAH2	1371	Q9P225
TLLVWAPNHYQVVKD	SLC15A1	461	P46059
RYVWKKDNVALTPSS	SDK1	606	Q7Z5N4
SSYTIPEAWLLLANV	SLC15A3	366	Q8IY34
SSDFPLSVDVIYKLW	SACS	521	Q9NZJ4
KPVVVLSSYWEDISH	DYSF	656	O75923
EIKEIPTGSWQLYHV	MEP1B	376	Q16820
YVRVVTEKSPTDWAL	DBNL	16	Q9UJU6
NVWIEFTKLAADPSV	KYAT3	51	Q6YP21
QAPALWIETTAYALL	C4A	1256	P0C0L4
KSSYEPLWNEQVVFT	OTOF	471	Q9HC10
EVEPLNSTAVHVYWK	PTPRF	716	P10586
LSFLEIWYTTAAVPK	OR6F1	66	Q8NGZ6
IWYTTAAVPKALAIL	OR6F1	71	Q8NGZ6
VTPKADIYSFAITLW	MOS	256	P00540
VIALKSSVEVYAWAP	MINK1	1131	Q8N4C8
GVPSKTDWVAITLYA	MRC1	76	P22897
ELPTYQKWISAASKL	SMG8	441	Q8ND04
LPYVALTAWSAINKV	RTN4IP1	181	Q8WWV3
VWKTTPYQVAAEISQ	TARS3	176	A2RTX5
KQVDAESWKTTPYQI	TARS1	91	P26639
YSLNISWEKPADNVT	USH2A	1376	O75445
WYQKKEFLSVATTAP	PHTF2	11	Q8N3S3
KKNVSINTVTYEWAP	TES	101	Q9UGI8
YLLQKWASLPTSVQV	SMYD4	11	Q8IYR2
YITPNFRKLSDSEVW	SLC6A1	271	P30531
LKVPDGTSAAWYILT	SMIM34	41	A8MWV9
AIVGYKDSPSVWAAV	PFN1	21	P07737
QQVLSWSYGEDVKPF	TBC1D25	181	Q3MII6
ILPRSSQYIKWIVSA	TMCO3	601	Q6UWJ1
LAWLIYSIAFTPKVV	TMEM121B	316	Q9BXQ6
SVVVYPTQDDLKWSL	TMEM132B	261	Q14DG7
VATSLAYLPEWKENI	TCAF1	896	Q9Y4C2
YNTKPVVAVTSNWED	FER1L5	566	A0AVI2
YALPLVVKVVDNWAF	FER1L5	1306	A0AVI2
LSNVSKRTEYWDNVP	RGS22	831	Q8NE09
TSLPYKWVVEAANLL	MYBL2	286	P10244
AWINTCKISPEEVYN	NSUN7	206	Q8NE18
QDGIVPSEWLSSVYK	GMCL2	351	Q8NEA9
SAEYLDRKPVWFQTV	PTCHD4	411	Q6ZW05
WEPLAVKLQTYKTAV	CCT3	496	P49368
WYPITVATNSREQKK	NAMPT	156	P43490
TWLNPDVVTTYLREK	PKHD1	476	P08F94
DSADAIWAIQKLYPV	PKHD1	3416	P08F94
IWAIQKLYPVVSVTS	PKHD1	3421	P08F94
AVSQVLKGYDWSLVP	SOX8	71	P57073
AVSQVLKGYDWTLVP	SOX9	76	P48436
DVIILTYPKSGTNWL	SULT2A1	36	Q06520
NPWDRKVVVYLVDTS	TDRD7	1061	Q8NHU6
SYASWIQSKVTELQP	PRSS8	276	Q16651
WSKTGLVVYDSSVPI	NOP2	341	P46087
VPVSWTALVHVKAEY	RHPN1	336	Q8TCX5
PFSEVIDWTKAAIVA	EXTL1	306	Q92935
KAAYWASQVSENRPV	ERVK-9	776	P63128
EWNEIKYILSIIPSS	PVALEF	76	A0A1B0GWK0
YASQKPWLLNATVEE	ABCC8	771	Q09428
KGIQIWKVPATDTYS	ALK	721	Q9UM73
PVAGWINALEAYQKT	CNDP2	136	Q96KP4
IRDKTAVPYFSNLVW	CLEC16A	211	Q2KHT3
WEQYKFPVVITRSSN	TGDS	181	O95455
KIQSFKPETYWVLQA	TOP3B	231	O95985
STASELRKPIYWIVA	VPS50	771	Q96JG6
SIDPEFYNSIVWIKE	WWP2	646	O00308
ITVNLVDAWEPYKAA	WASHC5	296	Q12768
ADWKPLVAKISSYVQ	TDRKH	446	Q9Y2W6
SVLIWDICSKYTPDI	MIOS	141	Q9NXC5
ITAKAYIIEQSPVWK	SPO16	151	Q5VVC0
QTNVLSKPEWYLAQV	RINT1	326	Q6NUQ1
VSWDPVQAVIDKYVV	TNN	461	Q9UQP3
ATVSWDPVQAAIDKY	TNN	636	Q9UQP3
ATVSWDPVQATIDKY	TNN	901	Q9UQP3
RIAYKNWETEITAQP	CLEC3B	151	P05452
IYWKLDSKAVPSQTV	SYCP1	806	Q15431
PSDVSLTAYQAWKLK	STYXL2	581	Q5VZP5
TYPKAGTTWIQEIVD	SULT1C2	46	O00338
LARWQPAIATVDSYV	TNC	1816	P24821
ANGVWKYDLTPAIQT	TMEM214	41	Q6NUQ4
FVYQAWITDPKTALR	PIEZO2	1581	Q9H5I5
EDVKPTYWAQSHLVT	TTC3	1301	P53804
ACPSVLYSEVLEWNK	KRT10-AS1	171	Q8N816
KLYVSSQWEVSQVPL	SEMA7A	476	O75326
ALVKENIPYSWASLA	RHPN2P1	246	A8MT19
PLLVDSEGWVKAQYE	PIGR	396	P01833
KQATPYIAVLVSSWF	SLC66A3	91	Q8N755
VYDTKDPAVTEWVLA	TLR7	896	Q9NYK1
VHITINEIYGKWSPL	PLCH1	851	Q4KWH8
KISIWPALTQVAIQY	ZBED6	891	P86452
YVTWKLSTFPANRVI	UEVLD	301	Q8IX04
IDSVIYKWNPATRLF	TSPEAR	451	Q8WU66
NETWYKVEALEPGTL	PTPRH	626	Q9HD43
LEVLYSLVSKISPDW	WDR7	146	Q9Y4E6
LPKEIYEVTSSQWVR	ZNF850	91	A8MQ14
VIVWDPFLNTSAAYI	TM7SF3	256	Q9NS93
VSAIVQRKYWTSKPE	TRIM16L	131	Q309B1
TLTAYAVPWTQKEFD	UGT1A4	76	P22310
KSVEVYDPTTNAWRQ	KLHL2	511	O95198
VTNPVDILTYVAWKL	LDHAL6A	136	Q6ZMR3
QVSPDDWKRSIVAYF	MYO7A	2071	Q13402